Targeted nanocurcumin therapy using annexin A2 antibody improves tumor accumulation and therapeutic efficacy against highly metastatic breast cancer

Fingerprint

Dive into the research topics of 'Targeted nanocurcumin therapy using annexin A2 antibody improves tumor accumulation and therapeutic efficacy against highly metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Engineering & Materials Science

Chemical Compounds